Trade Summary

4 days ago, Redmile Group, LLC, serving as 10% owner Owner at Attovia Therapeutics, Inc. (ATTO), purchased 600,000 shares at $17.00 per share, for a total transaction value of $10,200,000.00. Following this transaction, Redmile Group, LLC now holds 1,182,854 shares of ATTO.

This purchase represents a 102.94% increase in Redmile Group, LLC's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, August 6, 2026 and publicly disclosed via SEC Form 4 filing on Saturday, August 8, 2026 (accepted Aug 7, 9:47 PM ET), 2 days after the trade was made.